Unknown

Dataset Information

Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis.


ABSTRACT:

Background

Myo-inositol (or inositol) and its derivatives not only function as important metabolites for multiple cellular processes but also act as co-factors and second messengers in signaling pathways. Although inositol supplementation has been widely studied in various clinical trials, little is known about its effect on idiopathic pulmonary fibrosis (IPF). Recent studies have demonstrated that IPF lung fibroblasts display arginine dependency due to loss of argininosuccinate synthase 1 (ASS1). However, the metabolic mechanisms underlying ASS1 deficiency and its functional consequence in fibrogenic processes are yet to be elucidated.

Methods

Metabolites extracted from primary lung fibroblasts with different ASS1 status were subjected to untargeted metabolomics analysis. A

SUBMITTER: Li JM 

PROVIDER: S-EPMC10189934 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature